AC006050.3-003

Gene basic information

SymbolAC006050.3-003
Tissuelung,
Cancerlung squamous cell cancer,


Description

LncRNA AC006050.3-003 is lower in partial response (PR) samples compared with the progressive disease (PD) samples (1). It is a valuable biomarker for differentiating PR patients from PD patients and might correlate with the sensitivity of chemotherapy in lung squamous cell carcinoma patients.


Cancer related information

download as excel csv txt

LncRNA tissue cancer type expression level oncogene/suppress gene pathway binding gene/factor associated gene/factor proliferation apoptosis migration EMT invasion metastasis prognosis tag PMID
0 AC006050.3-003 lung lung squamous cell cancer / / chemotherapy resistance 25250788

Expression profile

adipose adrenal brain breast colon heart kidney leukocyte liver lung lymph node ovary prostate skeletal muscle testis thyroid tissue 0.00 0.05 0.10 0.15 0.20 0.25 0.30 fpkm 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.1 AC006050.3-003

Expression profile in human body map

TCGA-BLCA TCGA-BRCA TCGA-CESC TCGA-HNSC TCGA-KICH TCGA-KIRC TCGA-KIRP TCGA-LIHC TCGA-LUAD TCGA-LUSC TCGA-PRAD TCGA-STAD TCGA-THCA TCGA-UCEC tissue 0.00 0.02 0.04 0.06 0.08 0.10 0.12 fpkm AC006050.3-003 type normal tumor

Expression profile in TCGA


Genomic feature visualization


Sequence

Literature

[1]. Hou Z, Xu C, Xie H, Xu H, Zhan P, et al. (2014). Long noncoding RNAs expression patterns associated with chemo response to cisplatin based chemotherapy in lung squamous cell carcinoma patients. PLoS One 9(9): e108133. link pubmed



© Bioinformatics Group of XTBG